Biology Human Biology The biology of aging, or biogerontology, is the scientific field dedicated to understanding the fundamental mechanisms that drive the progressive, time-dependent decline in physiological function over an organism's lifespan. This discipline investigates a complex array of changes at the molecular and cellular levels, such as genomic instability, telomere attrition, mitochondrial dysfunction, and cellular senescence. These underlying processes collectively impair the ability of tissues and organs to maintain homeostasis and respond to stress, which in turn increases an organism's susceptibility to major age-related diseases like cancer, cardiovascular disorders, and neurodegeneration, making it a critical field for improving human healthspan and longevity.
1.1.
Defining Key Concepts
1.1.1.
Aging
1.1.1.1. Biological definition
1.1.1.2. Distinction from development and maturation
1.1.1.3. Primary aging vs secondary aging
1.1.1.4.1. Cellular senescence
1.1.1.4.2. Organismal senescence
1.1.2.
Lifespan
1.1.2.4. Species-specific variations
1.1.3.
Healthspan
1.1.3.1. Definition and measurement
1.1.3.2. Factors influencing healthspan
1.1.3.3. Relationship to lifespan
1.1.3.4. Quality-adjusted life years
1.1.4.
Longevity
1.1.4.1. Determinants of longevity
1.1.4.2. Longevity records in humans and animals
1.1.4.3. Exceptional longevity populations
1.1.4.4. Centenarians and supercentenarians
1.1.5.
Gerontology
1.1.5.2. Multidisciplinary nature
1.1.6.
Biogerontology
1.1.6.1. Distinction from general gerontology
1.1.6.2. Interdisciplinary nature
1.1.6.3. Research methodologies
1.2.
Historical Perspectives on Aging Research
1.2.1.
Early theories and observations
1.2.1.1. Ancient philosophical views
1.2.1.2. Early scientific observations
1.2.2.
Milestones in aging research
1.2.2.1. Discovery of cellular senescence
1.2.2.2. Development of model organisms
1.2.2.3. Molecular biology revolution
1.2.3.
Key figures in biogerontology
1.2.3.4. Other pioneering researchers
1.2.4.
Shifts in research paradigms
1.2.4.1. From descriptive to mechanistic
1.2.4.2. Single-factor to systems approaches
1.2.4.3. Therapeutic focus emergence
1.3.
Model Organisms in Aging Studies
1.3.1.
Criteria for model selection
1.3.1.2. Genetic tractability
1.3.1.3. Physiological relevance
1.3.1.4. Cost and maintenance
1.3.2.
Yeast (Saccharomyces cerevisiae)
1.3.2.1. Advantages and limitations
1.3.2.3. Replicative vs chronological aging
1.3.2.4. Genetic screens and pathways
1.3.3.
Nematodes (Caenorhabditis elegans)
1.3.3.2. Genetic manipulation
1.3.3.4. Insulin signaling discoveries
1.3.4.
Fruit Flies (Drosophila melanogaster)
1.3.4.3. Circadian rhythm studies
1.3.4.4. Stress resistance
1.3.5.
Killifish (Nothobranchius furzeri)
1.3.5.2. Relevance to vertebrate aging
1.3.5.3. Genetic diversity
1.3.5.4. Environmental adaptations
1.3.6.
Mice (Mus musculus)
1.3.6.2. Transgenic and knockout models
1.3.6.3. Caloric restriction studies
1.3.6.4. Pharmacological interventions
1.3.7.
Non-human Primates
1.3.7.1. Similarities to human aging
1.3.7.2. Ethical considerations
1.3.7.3. Rhesus macaque studies
1.3.7.4. Caloric restriction trials
1.3.8.
Comparative studies across species
1.3.8.1. Phylogenetic approaches
1.3.8.2. Scaling relationships
1.3.8.3. Evolutionary perspectives
1.4.
Distinguishing Aging from Age-Related Disease
1.4.1.
Definitions and boundaries
1.4.2.
Overlap and distinctions
1.4.3.
Examples of age-related diseases
1.4.3.1. Cardiovascular disease
1.4.3.3. Neurodegenerative disorders
1.4.3.4. Metabolic diseases
1.4.4.
Implications for research and intervention
1.4.5.
Compression of morbidity concept